Monoclonal antibodies—treatments developed by cloning a cell that makes an antibody—could help provide an answer to the growing problem of antimicrobial resistance, say scientists. A team lead by ...
Every winter, respiratory syncytial virus sends tens of thousands of U.S. infants to the hospital, filling pediatric ICU beds with babies struggling to breathe. Monoclonal antibodies have given ...
Hosted on MSN
Engineered antibody targets bacteria-specific sugar, clears lethal drug-resistant infection in mice
Australian researchers have developed a powerful new way to target deadly, drug-resistant bacteria by designing antibodies that recognize a sugar found only on bacterial cells—an advance that could ...
Our immune systems generate antibodies that neutralize and help eliminate foreign pathogens. These antibodies or proteins are generated by specific immune cells, which then recognize and bind to ...
Could monoclonal antibodies be the key to tackling the growing problem of antimicrobial resistance? A team led by researchers at the University of Cambridge has developed a monoclonal antibody drug ...
Graphic showing ‘triple-engineered antibody’, latches onto cancer cells on one end and draws in immune cells on the other. A new potential antibody therapy strategy which restricts the growth of ...
Our findings suggest that RAS amplification may confer resistance to anti-EGFR antibodies. Assessing RAS amplification status can help clinicians identify patients who may have a reduced benefit from ...
Monoclonal antibodies -- treatments developed by cloning a cell that makes an antibody -- could help provide an answer to the growing problem of antimicrobial resistance, say scientists. Monoclonal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results